Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus

BACKGROUND: Substance use (SU) contributes to poor health outcomes, yet limited data exist to inform strategies to optimize SU treatment among persons with human immunodeficiency virus (HIV). We describe SU and SU treatment utilization among women with and without HIV in the Women's Interagency...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Ayako W, Ramakrishnan, Aditi, Mehta, C Christina, Yusuf, Oyindamola B, Wilson, Tracey, Shoptaw, Steven, Carrico, Adam W, Adimora, Adaora A, Eaton, Ellen, Cohen, Mardge H, Cohen, Jennifer, Adedimeji, Adebola, Plankey, Michael, Jones, Deborah, Chandran, Aruna, Colasanti, Jonathan A, Sheth, Anandi N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835749/
https://www.ncbi.nlm.nih.gov/pubmed/36655189
http://dx.doi.org/10.1093/ofid/ofac684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835749/
https://www.ncbi.nlm.nih.gov/pubmed/36655189
http://dx.doi.org/10.1093/ofid/ofac684

Ejemplares similares